Treatment of Opioid Use Disorder With Buprenorphine Among US Adolescents and Young Adults During the Early COVID-19 Pandemic

PURPOSE: The COVID-19 pandemic’s impact on buprenorphine treatment for opioid use disorder among adolescents and young adults (AYAs) is unknown. METHODS: We used IQVIA Longitudinal Prescription Claims, including US AYAs aged 12–29 with at least 1 buprenorphine fill between January 2018 and August 20...

Descripción completa

Detalles Bibliográficos
Autores principales: Alinsky, Rachel H., Prichett, Laura, Chang, Hsien-Yen, Alexander, G. Caleb, Stein, Bradley D., Saloner, Brendan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society for Adolescent Health and Medicine. 2022
Materias:
Adolescent Health Brief
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110275/
https://www.ncbi.nlm.nih.gov/pubmed/35595609
http://dx.doi.org/10.1016/j.jadohealth.2022.03.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110275/
https://www.ncbi.nlm.nih.gov/pubmed/35595609
http://dx.doi.org/10.1016/j.jadohealth.2022.03.015

Ejemplares similares